A Japanese research team has developed a cyclic
peptide (a chain of amino acids bonded circularly) that enhances
blood-brain barrier (BBB) penetration. By attaching the cyclic
peptide to the surface of nanoparticles, research and development
of new drug nanocarriers for drug delivery to the brain becomes
possible.
If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!
The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.
If you wish to receive our latest news in your email box, just subscribe to our newsletter. We won’t spam you, we promise!
The New Fusion technology is based on a phenomenon called triplet-triplet annihilation (TTA) which is a process in which two triplet excitons annihilate and produce a higher energy singlet exciton.
